Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
Newsroom
Partnering News

Partnering News

Recent Partnership Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Medicines
Partnerships

September 2011

09.09.2011
Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials
- Partnerships

August 2011

08.29.2011
Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components
- Partnerships
08.16.2011
QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials for lung Cancer
- Partnerships
08.03.2011
Biotica regains worldwide rights to its rapamycin analogue program
- Partnerships

July 2011

07.07.2011
Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses
- Partnerships
07.05.2011
A prototype Handheld Device that Analyses DNA to Predict How Patients May Respond to their Prescription Medication has Performed Well in a Preliminary Pilot Study, Researchers Announce Today.
- Partnerships
07.05.2011
Cell Signaling Technology, Inc. Grants a Patent License to Pfizer
- Partnerships

June 2011

06.14.2011
pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma
- Partnerships
06.09.2011
Lpath Granted 22nd Patent Related to Lipidomics-Based Drug Development Program
- Partnerships
06.02.2011
Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China
- Partnerships
06.02.2011
Clovis Oncology, Inc. Receives License for Worldwide Development and Commercialization Rights to Pfizer’s Oral and IV PARP Inhibitor PF-01367338
- Partnerships

May 2011

05.10.2011
Foundation for the NIH Launches Trial to Develop Diabetes Diagnostic Tools
- Partnerships

Page 22
Page 23
Page 24
Current page 25
Page 26

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube